Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The program established a favorable safety profile but the Phase IIb endpoint did not differentiate sufficiently from placebo to support continued development for obesity
[PMID: 2526125] PubMed record related to this compound for laboratory literature review
Neurological symptoms such as paraesthesia, balance problems, or cognitive difficulties typically take 36 months to improve and may continue improving for up to 1218 months
Wang H et al
Vitamin B12 or folate deficiency anaemia Causes
GRAS Designation & Food Substance Classification In 2023, AOD-9604 received "Generally Recognized as Safe" (GRAS) designation from the FDA when submitted as a food substance or dietary supplement ingredient
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
